TP53 and prostate carcinoma: The anti-proliferative activity of InuA was evaluated by a BrdU cell proliferation assay, which showed a concentration-dependent and p53-independent inhibition of cell proliferation in androgen-sensitive and -resistant prostate cancer cell lines (Figure 1C).